Advanced Immunoisolation Membrane for Safe Transplants

The original patent disclosed a chamber for transplantation with a membrane for immunoisolation, which has limitations in terms of membrane permeability, damage susceptibility, and lack of adaptability to changing environmental conditions. The present invention addresses these limitations by introducing advanced membrane technologies that can dynamically respond to the needs of the transplant recipient, providing a more effective and safe transplantation process.

The present invention provides a paradigm shift in immunoisolation chamber technology by introducing advanced membrane technologies that can dynamically respond to the needs of the transplant recipient. The new claims are novel and non-obvious over the original patent, as they provide a more effective and safe transplantation process through the use of dynamically adjustable, self-healing, nanofiltration, shape-memory, and bio-hybrid membranes.

Alternative embodiments of the invention may include the use of different materials or structures for the dynamically adjustable membrane, such as electroactive polymers or microfluidic channels. The self-healing membrane may be achieved through the use of stimuli-responsive materials or encapsulated repair agents. The nanofiltration membrane may be designed with different pore sizes or surface chemistries to target specific immune cells or molecules. The shape-memory membrane may be designed to respond to different environmental stimuli, such as temperature, pH, or light. The bio-hybrid membrane may be composed of different ratios of biological and synthetic materials to optimize biocompatibility and immune response prevention.

The advanced immunoisolation chamber system has significant commercial potential in the field of transplantation, enabling more effective and safe transplantation of biological constituents. The market for transplantation devices is expected to grow significantly in the coming years, driven by the increasing need for organ and tissue transplants. The present invention is well-positioned to capture a significant share of this market, particularly in the areas of cell therapy, tissue engineering, and regenerative medicine.